ISRCTN49849003已完成不适用
A proof-of-concept study to evaluate the benefit from add-on therapy with montelukast versus salmeterol in children with asthma carrying the Arg/Arg-16 beta2-receptor genotype
niversity of Dundee (UK)0 个研究点目标入组 120 人开始时间: 2008年7月31日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All children and adolescents (5 - 18 years, either sex) with asthma in Tayside (Scotland) known:
- •1. To carry the Arg/Arg-16 genotype, and
- •2. Currently on inhaled steroids, and
- •3. Inhaled bronchodilators according to need
- •Will be telephoned or contacted through home visits to establish if they have had:
- •1. Any school absences from asthma, or
- •2. Out-of-hours visits to General Practitioner (GP)/hospital visits or admissions due to asthma over the previous 12 months
排除标准
- •The presence of serious respiratory or multi-system disease (e.g. cystic fibrosis, cancer under current treatment)
研究者
相似试验
进行中（未招募）
1 期
A Proof-of-Concept Study to evaluate the benefit from add-on therapy with montelukast versus salmeterol in children with asthma carrying the Arg/Arg-16 beta2-receptor genotypeAsthmaMedDRA version: 8.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2006-003264-65-GBniversity of Dundee
已完成
不适用
A Randomised, Double-blinded, Placebo-controlled Study of the probiotic PCC(Registered Trademark) (L. fermentum VRI-003) capsule for the effect on gastrointestinal health and gut microflora in healthy adults (with no medically diagnosed gastrointestinal disease)Gastrointestinal healthOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12616001052426Bioxyne Limited60
已完成
不适用
A proof of concept study to evaluate the impact of a food supplement on uptake and anti-inflammatory properties of omega-3 fatty acid derived specialized pro-resolution lipid mediatorsHealthy volunteersDRKS00023304Evonik Operations GmbH19
已完成
不适用
A proof of concept study to evaluate the impact of a food supplement on production of short chain fatty acids and microbiome in healthy subjectshealthy volunteersDRKS00023166Evonik Operations GmbH18
进行中（未招募）
1 期
A proof-of-concept study to assess the effect of ACT-451840 against early Plasmodium falciparum blood stage infection in healthy subjects.Infection - Other infectious diseasesMalariaACTRN12614000781640James McCarthy8